Hover over any project for a brief project description. Last updated December 2022. * Indicates a current project.
Economics Impacts Project*(AcademyHealth)
IVI and AcademyHealth have partnered to develop a framework for healthcare researchers to ensure we address the full range of economic impacts on patients and caregivers.
Patient-Engaged Healthcare Valuation*(RAND)
A proof-of-concept project testing a novel approach to “crowd-source” patient input using goal attainment scaling for use in deliberative methods (e.g., MCDA) to inform health technology assessment.
Patient-Driven Priorities for Management of MDD*(PAVE Center, University of Maryland)
Built on the PAVE Center’s Patient-Informed Value Element set, this project aims to elicit a set of value elements prioritized by people with MDD and quantify their preference for these elements in the context of treatment decisions, which will be used to augment the IVI-MDD value model.
IVI-MDD Value Model*(OPEN Health)
IVI’s third OSVP model, focusing on major depressive disorder (MDD), is being developed using a novel continual stakeholder engagement approach and will showcase novel methods in patient-centered research and value assessment.
Patient-Centered Core Impact Set*(National Health Council, EveryLife Foundation)
A multi-stakeholder effort to create a blueprint and toolkit that the patient community and other stakeholders can use to develop a patient-centered core impact set for specific diseases or populations.
MDD Treatment Patterns Retrospective Claims Study*(HealthCore)
A retrospective claims database analysis that examines real-world treatment patterns of people newly diagnosed with MDD and associated clinical and economic outcomes; results will inform the IVI-MDD value model.
IVI-MDD Model MCDA Module Working Group*(Chuck Phelps, Kevin Marsh)
A group of multi-criteria decision analysis (MCDA) experts convened to guide the development of the MCDA module of the IVI-MDD model to ensure its rigor and applicability to real-world decision contexts.
Scientific Spillover Methods Paper*(Adrian Towse, Lou Garrison)
A methods paper that examines the channels of influence of scientific spillover, a novel value element, and their magnitudes, with a particular focus on the value of failures in pharmaceutical R&D efforts.
Patient-Employer Roundtables(NHC, NAHPC)
Through roundtable discussions, National Health Council and National Alliance on Healthcare Purchasing Coalitions explored the alignment in value-related evidence needs between patients and employers and identified how value assessment approaches can better reflect both end-users’ view.